BLS Pharmaceuticals Limited (ASX: BLS)
Sector: Consumer Staples
Market cap: A$242M (as of 2 Nov 2026)
Biotechnology.
Data as of 2 Nov 2026.
Substantial holders — latest moves
Cash and runway
| Metric | Value | As of | Source |
|---|---|---|---|
| Cash | A$13M | 30 Sept 2026 | Filing ↗ |
Latest guidance
| Date | Period | Guidance | Source |
|---|---|---|---|
| 21 Oct 2026 | FY27 | Deliver FY27 growth with revenue guidance of $105m to $115m and adjusted EBITDA margin guidance of 23% to 26%. | Filing ↗ |
Ask about BLS in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has BLS raised money in the last year, and at what discount?
- What was BLS's latest cash position and runway?
Loading BLS…